Nokia Corporation (ADR)(NYSE:NOK)’s Chennai facility employees received support from Canadian author and Indophile Robin Jeffrey who believe that the factory has improved the life of the women in the nearby villages and is a much needed facility, according to a report from Economic Times. Chennai facility, which was due to be taken by Microsoft once it acquires Nokia device unit, is now in the middle of nowhere with workers in fear that they might lose their jobs. Nokia Corporation (ADR) (NYSE:NOK) shares after opening at $7.28 moved to $7.31 on last trade day and at the end of the day closed at $7.29. Company price to sales ratio in past twelve months was calculated as 1.56 and price to cash ratio as 2.14. Nokia Corporation (ADR) (NYSE:NOK) showed a negative weekly performance of -2.80%.
Gilead Sciences Inc. (NASDAQ:GILD) on Wednesday said its board has approved a stock repurchase plan of up to $5 billion. The plan is in addition to a separate $5 billion buyback program announced in January 2011, which has about $2.9 billion remaining and is expected to be completed by September, said Gilead. Gilead Sciences, Inc. (NASDAQ:GILD) shares advanced 0.57% in last trading session and ended the day on $78.77. GILD return on equity ratio is recorded as 38.90% and its return on assets is 19.10%. Gilead Sciences, Inc. (NASDAQ:GILD) yearly performance is 48.26%.
Sprint Corporation (NYSE:S) has reportedly collaborated with NQ Mobile Inc. (NQ) to allow its customers access to the latter’s NQ Music Radar technology on its latest smartphone, HTC One M8 Harman Kardon edition. Sprint Corporation (NYSE:S) shares moved up 0.58% in last trading session and was closed at $8.73, while trading in range of $8.64 – $8.88. Sprint Corporation (NYSE:S) year to date (YTD) performance is -18.79%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on Tuesday declared that it would provide a corporate update and report first quarter 2014 financial results after the NASDAQ Global Select Market closes on Monday, May 12, 2014. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) weekly performance is 7.03%. On last trading day company shares ended up $6.85. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 5.49%. Analysts mean target price for the company is $7.83.
Leave a Reply